(Date:5/12/2008)...LE #1 FOR IMMEDIATE RELEASE , Identifying abnor...rnal of Proteome Research , Researchers in Mass...e gaps in medical knowledge about the biochemical ...with diabetic retinopathy (DR) a leading cause of...cheduled for the June 6 issue of ACS monthly Journ...
(Date:5/11/2008)...The COMT gene known already for its role in schiz...mpsia, according to a report in todays advance on-...th Israel Deaconess Medical Center (BIDMC), the st..., may serve as both a diagnostic marker and therap...us pregnancy disorder. , Characterized by hypert...
(Date:5/9/2008)...n allows straightforward migration to EAC ePasspor.../ -- An innovator in ePassport,technology, Entrust...blic key,infrastructure to the Taiwanese governmen...tion stored on machine readable travel documents (...e available to nearly 23 million,citizens by the e...
(Date:5/9/2008)...ists at the University of Amsterdam have discovere...er lies at the molecular level. The story of how ... combating other plant diseases, is published May ... Farmers and fellow agriculturalists are continuou...evolve alongside their hosts immune system. In ag...
Breaking Biology News(10 mins):American Chemical Societys Weekly PressPac -- May 7, 2008 2American Chemical Societys Weekly PressPac -- May 7, 2008 3American Chemical Societys Weekly PressPac -- May 7, 2008 4American Chemical Societys Weekly PressPac -- May 7, 2008 5American Chemical Societys Weekly PressPac -- May 7, 2008 6American Chemical Societys Weekly PressPac -- May 7, 2008 7American Chemical Societys Weekly PressPac -- May 7, 2008 8A new gene trigger for pregnancy disorder identified 2Entrust, Hewlett Packard Partner to Deploy Taiwanese ePassports, Authenticate Biometric Data 2Entrust, Hewlett Packard Partner to Deploy Taiwanese ePassports, Authenticate Biometric Data 3SAFC Pharma to Increase Viral Product Manufacturing Capacity 2583 1SAFC Pharma to Increase Viral Product Manufacturing Capacity 2583 2SAFC Pharma to Increase Viral Product Manufacturing Capacity 2583 3VIRxSYS and Lentigen Announce Litigation Settlement 2579 1VIRxSYS and Lentigen Announce Litigation Settlement 2579 2MS Drug Tysabri Approved for Crohns Disease 9517 1MS Drug Tysabri Approved for Crohns Disease 9517 2MS Drug Tysabri Approved for Crohns Disease 9517 3Anyone can save a life 3A Penn researchers lead national efforts to improve CPR quality 9513 1Anyone can save a life 3A Penn researchers lead national efforts to improve CPR quality 9513 2Anyone can save a life 3A Penn researchers lead national efforts to improve CPR quality 9513 3(Date:5/12/2008)...RNewswire/ -- USGI Medical, Inc. (USGI),the leade...e company has,licensed its incisionless surgery te...use in medical robotics applications. Financial te...impressed by USGI,s technical and clinical develop...Gary Guthart, president and,chief operating office...
(Date:5/12/2008)...ire-FirstCall/ -- Synvista Therapeutics,Inc. (Ame...ocus with the,appointment of David C. Tantillo as ...ted position. Beginning today, Mr. Tantillo will b...cialization of the Company,s,haptoglobin diagnosti...,product in mid- 2009., Mr. Tantillo brings to Sy...
(Date:5/12/2008)...May 12 /- Forest,Laboratori...l company, and,Daiichi Sankyo, Inc. today announce...eement for AZOR(TM)* (amlodipine and olmesartan me...of two antihypertensives, the,calcium channel bloc...or,blocker olmesartan medoxomil. Forest will recor...
(Date:5/12/2008)...wswire/ -- ChemAxon, a software,solutions provider...ent of,Alex Drijver as CEO. The arrival signals th...t and market position. Ferenc Csizmadia, founder a...rch and Development. The new,R&D position formalis...mpany,s development strategy and in particular the...
Breaking Biology Technology:USGI Medical Licenses Incisionless Surgery Technology to Intuitive Surgical 2USGI Medical Licenses Incisionless Surgery Technology to Intuitive Surgical 3Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales 2Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales 3Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales 4Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 2Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 3Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 4...Madison Medical School has a new home: Health Sc...uare-foot building that will unify the health scie...about creating the future of medicine, said Paul ...studies at UW Medical School. , ,The center will b...ical therapy students in one facility. DeLuca said...
... are no longer a pipe dream. That was the message ...nel discussion of Voice over Internet Protocol, or...ns over existing data networks has stirred excitem...P telephony specialist with Cisco Systems , descr... to a phone jack but to an Ethernet port, and his ...
...e brains of some of the Internet,s earliest entrep... of Web browser tools designed to make finding and...s today. , ,At DEMO 2004, three companies - BIGont...roblem with tools that helped manage Web search re...sembled team from the Allaire Software days introd...
...Hospital has completed its hospital-wide deployme...n, with the final system being implemented in the ...by McKesson Automation Inc. , is now operational ...rted to reduce medication administration errors by... of a hand-held, wireless bar code scanner that ca...
Other Biology Technology:UW Medical School to build Health Sciences Learning Center 2VoIP experts assess early implementations 2VoIP experts assess early implementations 3Plucking information from the web 2Plucking information from the web 3Plucking information from the web 4UW Hospital completes deployment of error-reducing technology 2UW Hospital completes deployment of error-reducing technology 3...ixation Buffer, used in conjunction with eBioscien... be used to fix and permeabilize cells prior to pe...ther cytoplasmic and/or nuclear antigens. These so...g non-specific staining by fluorochrome-labelled a...
Perm Buffer III is intented for permeabilization following fixation of PBMCs (or lysed whole blood) for staining for intracellular kinases and appropriate CD markers simultaneously. Applications: In
Permeabilization Solution, 5X
Perm/Wash Buffer 250 Tests
Biology Products: